ASL, argininosuccinate lyase, 435

N. diseases: 99; N. variants: 85
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 GeneticVariation disease BEFREE We identified compound heterozygous mutations of the argininosuccinate lyase (ASL) gene in a Chinese Han ASAuria patient. 26843370 2016
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 GeneticVariation disease BEFREE Here, we are providing an update on the molecular basis of ASLD by collecting all published (n = 67) as well as novel mutations (n = 67) of the ASL gene. 24166829 2014
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 Biomarker disease BEFREE We show that a hypomorphic mouse model of argininosuccinate lyase (encoded by Asl) deficiency has a distinct phenotype of multiorgan dysfunction and NO deficiency. 22081021 2011
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 Biomarker disease BEFREE Deficiency of AL leads to the human urea cycle disorder argininosuccinic aciduria. 12559843 2003
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 GeneticVariation disease BEFREE Compound heterozygous p.Lys69Arg and p.Arg213∗ mutations that resulted in reduced ASL enzyme activity were found in a patient with ASLD. 31183366 2019
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 GeneticVariation disease BEFREE We have identified a common novel mutation (Q354X) in the argininosuccinate lyase (ASL) gene in Saudi patients with argininosuccinic aciduria (ASAuria; McKusick 207900). 16435180 2005
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 Biomarker disease BEFREE This review describes the structure and function of ASL and its homologue delta crystallin, the genetic defects associated with argininosuccinic aciduria and current theories regarding complementation in this protein. 11092456 2000
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 Biomarker disease BEFREE Our data emphasize ASL importance for the metabolic regulation of LC function with translational relevance for ASL deficiency (ASLD) patients as well as for LC-related pathologies. 31747589 2019
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 GeneticVariation disease BEFREE Argininosuccinic aciduria: assignment of the argininosuccinate lyase gene to the pter to q22 region of human chromosome 7 by bioautography. 282632 1978
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 GeneticVariation disease BEFREE This study aimed at the completion of the structure and the sequence of the human ASL gene, the development of a genomic DNA-based system for mutation analysis and, finally, the characterisation of the molecular genetic background of ASL deficiency in 27 unrelated patients. 12384776 2002
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 AlteredExpression disease BEFREE These findings suggest that the clinical and biochemical course in variant forms of ASLD is associated with relevant residual levels of ASL activity as well as instability of mutant ASL proteins. 25778938 2015
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 Biomarker disease BEFREE Deficiency of ASL results in an accumulation of argininosuccinic acid in tissues, and excretion of argininosuccinic acid in urine leading to the condition argininosuccinic aciduria (ASA). 21312326 2011
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 GeneticVariation disease BEFREE Six individuals with ASAL deficiency had alleles that led to a complete absence of exon 13 from the ASL mRNA; each had a partial deletion of exon 13 in the genomic DNA. 16941645 2006
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 Biomarker disease BEFREE Our results suggest that ASL transcripts can contribute to the highly variable phenotype in ASA patients if expressed at high levels. 24136197 2013
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 GeneticVariation disease BEFREE Two new pathogenic mutations of ASL gene, c.208-15 T>A and c.281G>T, were found in an ASA family, which enriches the mutational profile of the ASL gene and provides a basis for genetic diagnosis of ASA. 31156699 2019
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 Biomarker disease BEFREE In this article, we discuss the natural history of ASA and the recent mechanistic insights from animal studies that have shown the requirement of argininosuccinate lyase, the enzyme deficient in ASA, for systemic nitric oxide production. 22841516 2012
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 AlteredExpression disease BEFREE Neonatal argininosuccinic aciduria with normal brain and kidney but absent liver argininosuccinate lyase activity. 174426 1976
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 Biomarker disease BEFREE Using data from a human clinical study, a mouse model with endothelial-specific deletion of argininosuccinate lyase (Asl), and in vitro studies in human aortic endothelial cells and induced pluripotent stem cell-derived endothelial cells from individuals with ASLD, we show that loss of ASL in endothelial cells leads to endothelial-dependent vascular dysfunction with reduced nitric oxide (NO) production, increased oxidative stress, and impaired angiogenesis. 30075114 2018
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 Biomarker disease BEFREE Here, we present a collaborative review, which highlights these recent discoveries and novel emerging concepts about ASL role in human physiology, ASA clinical phenotype and geographic prevalence, limits of current standard of care and newborn screening, pathophysiology of the disease, and emerging novel therapies. 30723942 2019
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 AlteredExpression disease BEFREE Here, we developed a gene therapy strategy for ASA aimed at alleviating the symptoms associated with urea cycle disruption by providing stable expression of ASL protein in the liver. 30253962 2018
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 CausalMutation disease CLINVAR Unstable argininosuccinate lyase in variant forms of the urea cycle disorder argininosuccinic aciduria. 25778938 2015
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 CausalMutation disease CLINVAR Here, we are providing an update on the molecular basis of ASLD by collecting all published (n = 67) as well as novel mutations (n = 67) of the ASL gene. 24166829 2014
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 CausalMutation disease CLINVAR Hereditary urea cycle diseases in Finland. 18616627 2008
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 GeneticVariation disease CLINVAR Argininosuccinate lyase deficiency: mutational spectrum in Italian patients and identification of a novel ASL pseudogene. 17326097 2007
CUI: C0268547
Disease: Argininosuccinic Aciduria
Argininosuccinic Aciduria
1.000 CausalMutation disease CLINVAR Three-dimensional structure of the argininosuccinate lyase frequently complementing allele Q286R. 11747432 2001